ReviewCurrent cardiology reports2014
Management of symptomatic carotid disease in 2014.
Review in Current cardiology reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Outcomes of transcarotid artery revascularization: A systematic review.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024Pooled it
- Carotid Artery Stenosis: A Look Into the Diagnostic and Management Strategies, and Related Complications.Cureus · 2023Review
- Postoperative Intensive Care Management of Aortic Repair.Journal of personalized medicine · 2022Review
- Anatomic eligibility for transcarotid artery revascularization and transfemoral carotid artery stenting.Journal of vascular surgery · 2019Article
- Changes in chorioretinal blood flow velocity and cerebral blood flow after carotid endarterectomy.Japanese journal of ophthalmology · 2016Observational
- Amaurosis fugax: risk factors and prevalence of significant carotid stenosis.Clinical ophthalmology (Auckland, N.Z.) · 2016Article
- Amaurosis fugax - delay between symptoms and surgery by specialty.Clinical ophthalmology (Auckland, N.Z.) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracranial carotid artery stenosis accounts for up to 12 % of stroke, the third leading cause of death in industrialized nations. Carotid stenoses leading to transient or permanent neurologic or retinal symptoms within the preceding 6 months are deemed symptomatic and require prompt noninvasive evaluation and treatment. Preventive medical therapy is standard for symptomatic carotid stenosis and continues to evolve. Landmark trials have proven carotid endarterectomy (CEA) superior to medical therapy for stroke prevention in symptomatic lesions. Modern investigations have proven carotid artery stenting (CAS) non-inferior to CEA, and the strength of the combined data has led to a class I recommendation for CEA or CAS in patients with high grade symptomatic carotid stenosis, provided the risk of perioperative events is acceptable. Evidence-based modern management of symptomatic carotid stenosis is reviewed here.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.